Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

cyclopia sequence 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Tuberous Sclerosis 1Sezary Syndrome 1Seizures 1Prostatic Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lung Neoplasms 1Lennox Gastaut Syndrome 1Epilepsy 1Epilepsies, Myoclonic 1Carcinoma, Non-Small-Cell Lung 1Advanced Cancers 1Adenomatous Polyposis Coli 1

Interventions

Carboplatin 18Radiotherapy 10Cisplatin 10Pemetrexed 8Paclitaxel 8durvalumab 6Magnetic Resonance Spectroscopy 6Gemcitabine 6Radiosurgery 5Nivolumab 5Etoposide 5pembrolizumab 4atezolizumab 4Surveys and Questionnaires 4Radiation 4Erlotinib Hydrochloride 4Docetaxel 4Taxes 3Standard of Care 3Specimen Handling 3Platinum 3Cetuximab 3Bronchoscopy 3Biopsy 3Bevacizumab 31,2-diaminocyclohexaneplatinum II citrate 3sapanisertib 2etoposide phosphate 2capmatinib 2Vinorelbine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Lung Neoplasms × Curcumin × Clear all
NCT01048983 2015-03-05

Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Thoracic

cyclopia sequence, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡